See also this year's filing and all EDGAR filings for this company.
PDF Report 0001534120_2020_Avalo_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001534120, Avalo Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 17,724,016 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 16,835,346 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,549,608 |
| 4 | LiabilitiesCurrent | 12,160,459 |
| 5 | LiabilitiesNoncurrent | 1,111,965 |
| 6 | remainder_Liabilities | 1,840,981 |
| 7 | CostOfGoodsAndServicesSold | -566,523 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,123,320 |
| 9 | ResearchAndDevelopmentExpense | 11,764,133 |
| 10 | remainder_Expenses | 1,847,145 |
| 11 | remainder_Revenues | 6,750,351 |
| 12 | remainder_NetIncome | 345,177 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 36,108,970 |
| 1 | Liabilities | 15,113,405 |
| 2 | Expenses | 23,168,075 |
| 3 | Revenues | 6,750,351 |
| 4 | StockholdersEquity | 20,995,565 |
| 5 | NetIncome | -16,072,547 |
| 6 | ComprehensiveNetIncome | -16,072,547 |
| 7 | BaseVar | 40,742,989 |
| 8 | EconomicCapitalRatio | 0.782 |
Edgar->Model Mapping
Feature Distribution
Change over Time
